Initial Real-World Evidence for Lecanemab in the United States.
Saved in:
| Title: | Initial Real-World Evidence for Lecanemab in the United States. |
|---|---|
| Authors: | Brixner DI; Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake, UT, USA., Zhao C; Eisai Inc., Nutley, NJ, USA. chenyue_zhao@eisai.com., Toyosaki H; Eisai Inc., Nutley, NJ, USA., Frech FH; Eisai Inc., Nutley, NJ, USA., Rosenbloom MH; Memory and Brain Wellness Center, University of Washington, Seattle, WA, USA. |
| Source: | Drugs & aging [Drugs Aging] 2026 Jan; Vol. 43 (1), pp. 69-76. Date of Electronic Publication: 2025 Oct 29. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1969 (Electronic) Linking ISSN: 1170229X NLM ISO Abbreviation: Drugs Aging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1969 |
|---|---|
| DOI: | 10.1007/s40266-025-01261-x |
